文献速递免疫规划传染病防控与疫情报告

口服减毒假结核耶尔森菌递送FliC180-LcrV融合抗原对肺鼠疫感染提供保护

Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
PubMed 文献 · Vaccine · 2020-04-08

在假结核耶尔森菌突变株(Δasd ΔyopJ ΔyopK)基础上引入ΔPfur::TT araC PBADfur缺失插入突变构建Yptb5株,实现阿拉伯糖依赖的可调控延迟fur关闭。Yptb5递送佐剂化融合蛋白FliC180-LcrV,小鼠口服5×10^8 CFU后诱导高抗体滴度、平衡Th1/Th2应答及强T细胞应答,对5.5×10^3 CFU(55 LD50)肺鼠疫攻击提供完全保护,对100 LD50仅50%存活。

要点

  • Yptb5株在阿拉伯糖依赖调控下延迟关闭fur,保留强免疫原性。
  • 口服Yptb5(pSMV4)或Yptb5(pSMV8)均诱导高抗体滴度及平衡Th1/Th2应答。
  • 对5.5×10^3 CFU(55 LD50)鼠疫耶尔森菌攻击完全保护,100 LD50仅50%存活。

核心结论

  • 阿拉伯糖依赖的可调控延迟fur关闭是开发保留强免疫原性减毒活菌疫苗的有效策略。

研究设计与样本

  • 在假结核耶尔森菌突变株(Δasd ΔyopJ ΔyopK)基础上构建Yptb5株,并比较pSMV4与pSMV8质粒递送FliC180-LcrV的效果。
  • 小鼠经口接种5×10^8 CFU的Yptb5(pSMV4)或Yptb5(pSMV8)株。

主要发现

  • Yptb5(pSMV4)与Yptb5(pSMV8)的FliC180-LcrV合成水平相同,在小鼠组织中的载量分布模式相似。
  • 口服接种小鼠产生高抗体滴度、平衡Th1/Th2应答,以及产生IFN-γ、IL-17A和TNF-α的强T细胞应答。
  • 对5.5×10^3 CFU(55 LD50)鼠疫耶尔森菌肺部攻击完全保护,对100 LD50攻击仅50%存活(部分保护)。

关键数值与推荐

  • 小鼠口服接种剂量为5×10^8 CFU的Yptb5(pSMV4)或Yptb5(pSMV8)株。
  • 肺部攻击剂量为5.5×10^3 CFU(55 LD50)时完全保护,100 LD50时50%存活。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We incorporated the ΔPfur::TT araC PBADfur deletion-insertion mutation on top of a previous Yersinia pseudotuberculosis mutant (Δasd ΔyopJ ΔyopK) to construct a new mutant designated as Yptb5, which manifests the arabinose-dependent regulated delayed fur (encoding ferric uptake regulator) shut-off. The Yptb5 strain was used to deliver an adjuvanted fusion protein, FliC180-LcrV. Levels of FliC180-LcrV synthesis were same in Yptb5 either harboring pSMV4, a p15A ori plasmid or pSMV8, a pSC101 ori plasmid containing the fliC180-lcrV fusion gene driven by Ptrc promoter. Tissue burdens of both Yptb5(pSMV4) and Yptb5(pSMV8) in mice had similar patterns. Mice vaccinated orally with 5 × 108 CFU of either Yptb5(pSMV4) or Yptb5(pSMV8) strain were primed high antibody titers with a balanced Th1/Th2 response, also developed potent T-cell responses with significant productions of IFN-γ, IL-17A and TNF-α. Immunization with each mutant strain conferred complete protection against pulmonary challenge with 5.5 × 103 CFU (55 LD50) of Y. pestis, but partial protection (50% survival) against 100 LD50 of Y. pestis. Our results demonstrate that arabinose-dependent regulated delayed fur shut-off is an effective strategy to develop live attenuated bacterial vaccines while retaining strong immunogenicity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Singh AK, Wang X, Sun W, et al. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection. Vaccine. 2020. PMID: 32278523. doi:10.1016/j.vaccine.2020.03.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。